2020 annual financial data
Cullinan Therapeutics 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -157.17%.
Operating income was -60,335,000 USD and net income was -50,849,000 USD.
Operating cash flow was -29,772,000 USD.
Get free Cullinan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,943,000 USD
- Operating income
- -60,335,000 USD
- Net income
- -50,849,000 USD
- Operating cash flow
- -29,772,000 USD